Genome-wide aberrations in pancreatic adenocarcinoma

Norma J. Nowak, Daniel Gaile, Jeffrey M. Conroy, Devin McQuaid, John Kenneth Cowell, Randy Carter, Michael G. Goggins, Ralph H. Hruban, Anirban Maitra

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Chromosomal instability, manifesting as copy number alterations (CNAs), is characteristic of pancreatic adenocarcinoma. We used bacterial artificial chromosome (BAC) array-based comparative genomic hybridization (aCGH) to examine the pancreatic adenocarcinoma genome for submicroscopic amplifications and deletions. Profiles of 33 samples (17 first-passage xenografts and 16 cell lines) identified numerous chromosomal regions with CNAs, including losses at 1p36.33∼p34.3, 1p13.3∼p13.2, 3p26, 3p25.2∼p22.3, 3p22.1∼p14.1, 4q28.3, 4q31, 4q35.1, 5q14.3, 6p, 6q, 8p23.3∼p12, 9p, 9q22.32∼q31.1, 13q33.2, 15q11.2, 16p13.3, 17p, 18q11.21∼q23 , 19p13.3∼p13.12, 19q13.2, 21p, 21q, and 22p, 22q and gains at 7p21.1∼p11.2, 7q31.32, 7q33, 8q11.1∼q24, 11p13, 14q22.2, 20p12.2, and 20q11.23∼q13.33. Novel regions containing CNAs were identified and refined by combining the increased resolution of our BAC CGH array with a statistical algorithm developed for assigning significance values to altered BACs across samples. A subset of array-based CNAs was validated using polymerase chain reaction-based techniques, immunohistochemistry and fluorescence in situ hybridization. BAC aCGH proved to be a powerful genome-wide strategy to identify molecular alterations in pancreatic cancer and to distinguish differences between cell line and xenograft aberration profiles. These findings should greatly facilitate further research in understanding the pathogenesis of this lethal disease, and could lead to the identification of novel therapeutic targets and biomarkers for early detection.

Original languageEnglish (US)
Pages (from-to)36-50
Number of pages15
JournalCancer Genetics and Cytogenetics
Volume161
Issue number1
DOIs
StatePublished - Aug 1 2005
Externally publishedYes

Fingerprint

Bacterial Artificial Chromosomes
Adenocarcinoma
Comparative Genomic Hybridization
Genome
Heterografts
Cell Line
Chromosomal Instability
Fluorescence In Situ Hybridization
Pancreatic Neoplasms
Biomarkers
Immunohistochemistry
Polymerase Chain Reaction
Research
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Nowak, N. J., Gaile, D., Conroy, J. M., McQuaid, D., Cowell, J. K., Carter, R., ... Maitra, A. (2005). Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genetics and Cytogenetics, 161(1), 36-50. https://doi.org/10.1016/j.cancergencyto.2005.01.009

Genome-wide aberrations in pancreatic adenocarcinoma. / Nowak, Norma J.; Gaile, Daniel; Conroy, Jeffrey M.; McQuaid, Devin; Cowell, John Kenneth; Carter, Randy; Goggins, Michael G.; Hruban, Ralph H.; Maitra, Anirban.

In: Cancer Genetics and Cytogenetics, Vol. 161, No. 1, 01.08.2005, p. 36-50.

Research output: Contribution to journalArticle

Nowak, NJ, Gaile, D, Conroy, JM, McQuaid, D, Cowell, JK, Carter, R, Goggins, MG, Hruban, RH & Maitra, A 2005, 'Genome-wide aberrations in pancreatic adenocarcinoma', Cancer Genetics and Cytogenetics, vol. 161, no. 1, pp. 36-50. https://doi.org/10.1016/j.cancergencyto.2005.01.009
Nowak, Norma J. ; Gaile, Daniel ; Conroy, Jeffrey M. ; McQuaid, Devin ; Cowell, John Kenneth ; Carter, Randy ; Goggins, Michael G. ; Hruban, Ralph H. ; Maitra, Anirban. / Genome-wide aberrations in pancreatic adenocarcinoma. In: Cancer Genetics and Cytogenetics. 2005 ; Vol. 161, No. 1. pp. 36-50.
@article{5294eaa37b2945579e226e36deeffd9e,
title = "Genome-wide aberrations in pancreatic adenocarcinoma",
abstract = "Chromosomal instability, manifesting as copy number alterations (CNAs), is characteristic of pancreatic adenocarcinoma. We used bacterial artificial chromosome (BAC) array-based comparative genomic hybridization (aCGH) to examine the pancreatic adenocarcinoma genome for submicroscopic amplifications and deletions. Profiles of 33 samples (17 first-passage xenografts and 16 cell lines) identified numerous chromosomal regions with CNAs, including losses at 1p36.33∼p34.3, 1p13.3∼p13.2, 3p26, 3p25.2∼p22.3, 3p22.1∼p14.1, 4q28.3, 4q31, 4q35.1, 5q14.3, 6p, 6q, 8p23.3∼p12, 9p, 9q22.32∼q31.1, 13q33.2, 15q11.2, 16p13.3, 17p, 18q11.21∼q23 , 19p13.3∼p13.12, 19q13.2, 21p, 21q, and 22p, 22q and gains at 7p21.1∼p11.2, 7q31.32, 7q33, 8q11.1∼q24, 11p13, 14q22.2, 20p12.2, and 20q11.23∼q13.33. Novel regions containing CNAs were identified and refined by combining the increased resolution of our BAC CGH array with a statistical algorithm developed for assigning significance values to altered BACs across samples. A subset of array-based CNAs was validated using polymerase chain reaction-based techniques, immunohistochemistry and fluorescence in situ hybridization. BAC aCGH proved to be a powerful genome-wide strategy to identify molecular alterations in pancreatic cancer and to distinguish differences between cell line and xenograft aberration profiles. These findings should greatly facilitate further research in understanding the pathogenesis of this lethal disease, and could lead to the identification of novel therapeutic targets and biomarkers for early detection.",
author = "Nowak, {Norma J.} and Daniel Gaile and Conroy, {Jeffrey M.} and Devin McQuaid and Cowell, {John Kenneth} and Randy Carter and Goggins, {Michael G.} and Hruban, {Ralph H.} and Anirban Maitra",
year = "2005",
month = "8",
day = "1",
doi = "10.1016/j.cancergencyto.2005.01.009",
language = "English (US)",
volume = "161",
pages = "36--50",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Genome-wide aberrations in pancreatic adenocarcinoma

AU - Nowak, Norma J.

AU - Gaile, Daniel

AU - Conroy, Jeffrey M.

AU - McQuaid, Devin

AU - Cowell, John Kenneth

AU - Carter, Randy

AU - Goggins, Michael G.

AU - Hruban, Ralph H.

AU - Maitra, Anirban

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Chromosomal instability, manifesting as copy number alterations (CNAs), is characteristic of pancreatic adenocarcinoma. We used bacterial artificial chromosome (BAC) array-based comparative genomic hybridization (aCGH) to examine the pancreatic adenocarcinoma genome for submicroscopic amplifications and deletions. Profiles of 33 samples (17 first-passage xenografts and 16 cell lines) identified numerous chromosomal regions with CNAs, including losses at 1p36.33∼p34.3, 1p13.3∼p13.2, 3p26, 3p25.2∼p22.3, 3p22.1∼p14.1, 4q28.3, 4q31, 4q35.1, 5q14.3, 6p, 6q, 8p23.3∼p12, 9p, 9q22.32∼q31.1, 13q33.2, 15q11.2, 16p13.3, 17p, 18q11.21∼q23 , 19p13.3∼p13.12, 19q13.2, 21p, 21q, and 22p, 22q and gains at 7p21.1∼p11.2, 7q31.32, 7q33, 8q11.1∼q24, 11p13, 14q22.2, 20p12.2, and 20q11.23∼q13.33. Novel regions containing CNAs were identified and refined by combining the increased resolution of our BAC CGH array with a statistical algorithm developed for assigning significance values to altered BACs across samples. A subset of array-based CNAs was validated using polymerase chain reaction-based techniques, immunohistochemistry and fluorescence in situ hybridization. BAC aCGH proved to be a powerful genome-wide strategy to identify molecular alterations in pancreatic cancer and to distinguish differences between cell line and xenograft aberration profiles. These findings should greatly facilitate further research in understanding the pathogenesis of this lethal disease, and could lead to the identification of novel therapeutic targets and biomarkers for early detection.

AB - Chromosomal instability, manifesting as copy number alterations (CNAs), is characteristic of pancreatic adenocarcinoma. We used bacterial artificial chromosome (BAC) array-based comparative genomic hybridization (aCGH) to examine the pancreatic adenocarcinoma genome for submicroscopic amplifications and deletions. Profiles of 33 samples (17 first-passage xenografts and 16 cell lines) identified numerous chromosomal regions with CNAs, including losses at 1p36.33∼p34.3, 1p13.3∼p13.2, 3p26, 3p25.2∼p22.3, 3p22.1∼p14.1, 4q28.3, 4q31, 4q35.1, 5q14.3, 6p, 6q, 8p23.3∼p12, 9p, 9q22.32∼q31.1, 13q33.2, 15q11.2, 16p13.3, 17p, 18q11.21∼q23 , 19p13.3∼p13.12, 19q13.2, 21p, 21q, and 22p, 22q and gains at 7p21.1∼p11.2, 7q31.32, 7q33, 8q11.1∼q24, 11p13, 14q22.2, 20p12.2, and 20q11.23∼q13.33. Novel regions containing CNAs were identified and refined by combining the increased resolution of our BAC CGH array with a statistical algorithm developed for assigning significance values to altered BACs across samples. A subset of array-based CNAs was validated using polymerase chain reaction-based techniques, immunohistochemistry and fluorescence in situ hybridization. BAC aCGH proved to be a powerful genome-wide strategy to identify molecular alterations in pancreatic cancer and to distinguish differences between cell line and xenograft aberration profiles. These findings should greatly facilitate further research in understanding the pathogenesis of this lethal disease, and could lead to the identification of novel therapeutic targets and biomarkers for early detection.

UR - http://www.scopus.com/inward/record.url?scp=23244467697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244467697&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2005.01.009

DO - 10.1016/j.cancergencyto.2005.01.009

M3 - Article

VL - 161

SP - 36

EP - 50

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -